Stay updated on IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial page.

Latest updates to the IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedA new site revision entry, v3.5.4, was added to the record history, replacing the previous revision v3.5.3. This indicates a small update to the page's backend/metadata rather than content changes.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page footer/update indicator was updated from revision v3.5.2 to v3.5.3, reflecting a site software version change rather than a change to the clinical trial record.SummaryDifference0.1%

- Check38 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.1%

- Check67 days agoChange DetectedRevision history now includes v3.5.0 and removes v3.4.3; this change updates revision metadata only.SummaryDifference0.1%

- Check74 days agoChange DetectedAdded Revision: v3.4.3 to the history and removed Revision: v3.4.2.SummaryDifference0.1%

- Check103 days agoChange DetectedThe history now shows a new site revision (v3.4.2) replacing v3.4.1; there are no substantive updates to study records or page content, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial page.